Rate My Professor Bhuvanendran Pillai

Dr. B. Saatheeyavaane Bhuvanendran Pillai serves as a Lecturer in Neuroscience at the Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia. She obtained her Bachelor of Science degree from AIMST University in 2008 and her Doctor of Philosophy from Monash University in 2019, with her doctoral research focusing on the neuroprotective effects of embelin in experimental models of Alzheimer's disease. Her research specializes in precision neuroscience for neurological and mental health disorders, advancing translational approaches to enhance understanding and treatment of brain health conditions. Pillai integrates molecular biology, neuropharmacology, and nanoformulation-based delivery systems to investigate disease mechanisms, particularly in neurodegeneration and brain cancer. Her work encompasses neurochemical pathways, biomarker discovery, precision interventions, and innovative therapeutic strategies, contributing to targeted therapies for complex neurological challenges.

In her academic career at Monash University Malaysia, Pillai has produced 37 research outputs, comprising 18 articles, 17 review articles, and 2 meeting abstracts. Notable publications include 'Carotenoids Modulate FoxO-Induced Cell Cycle Arrest in Human Cancer Cell Lines: A Scoping Review' (2025, Food Science and Nutrition), 'Daily Supplementation of High Doses of Tocotrienol-Rich Fraction From Palm Oil Produced No Toxic Effects in Healthy Mice' (2025, Journal of Toxicology), 'Delta- and Gamma-Tocotrienols Inhibit the Proliferation of HCC2998 Human Colorectal Carcinoma Cells via Modulation of Histone Modification Pathways Involved in DNA Damage Response' (2025, Cell Biology International), 'Epigenetic modulations and nutrient interactions in Alzheimer's disease: unveiling potential therapeutic pathways' (2025, Nutritional Neuroscience), and 'Inhibition of Proliferation and Induction of Apoptosis by Gamma- or Delta-Tocotrienols in Human Colorectal Carcinoma Cells' (2025, BioMed Research International). She has earned recognition for her contributions, including a shared Bronze medal at PECIPTA in 2017, an award for a novel anti-NRP2 monoclonal antibody-based therapeutic against Chikungunya virus in 2021, Best e-poster presentation for enhancing medical students' understanding of basic immunology in 2024, and the PVC's Commendation Award for Innovation in Teaching and Learning in 2025. Pillai teaches units such as BRM5014 Therapeutic approaches and biotechnology and supervises biotechnology research projects, fostering the next generation of researchers through active collaborations with experts in immunology, pharmacology, and molecular biology.